NEUROCRINE BIOSCIENCES, INC. (NBIX) Net margin 2016–2025
NEUROCRINE BIOSCIENCES, INC. (NBIX) net profit margin by fiscal year — reported net income divided by reported revenue.
16.7%FY2025 · since FY2016: -940.6% → 16.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 16.7% | +2.2 pp |
| FY2024 | 14.5% | +1.3 pp |
| FY2023 | 13.2% | +2.9 pp |
| FY2022 | 10.4% | +2.5 pp |
| FY2021 | 7.9% | -31.0 pp |
| FY2020 | 38.9% | +34.2 pp |
| FY2019 | 4.7% | +0.0 pp |
| FY2018 | 4.7% | +92.9 pp |
| FY2017 | -88.2% | +852.4 pp |
| FY2016 | -940.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice